In Vitro Potential of Equine DEFA1 and eCATH1 as Alternative Antimicrobial Drugs in Rhodococcosis Treatment
- 1 April 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (4) , 1749-1755
Abstract
Rhodococcus equi , the causal agent of rhodococcosis, is a severe pathogen of foals but also of immunodeficient humans, causing bronchopneumonia. The pathogen is often found together with Klebsiella pneumoniae or Streptococcus zooepidemicus in foals. Of great concern is the fact that some R. equi strains are already resistant to commonly used antibiotics. In the present study, we evaluated the in vitro potential of two equine antimicrobial peptides (AMPs), eCATH1 and DEFA1, as new drugs against R. equi and its associated pathogens. The peptides led to growth inhibition and death of R. equi and S. zooepidemicus at low micromolar concentrations. Moreover, eCATH1 was able to inhibit growth of K. pneumoniae . Both peptides caused rapid disruption of the R. equi membrane, leading to cell lysis. Interestingly, eCATH1 had a synergic effect together with rifampin. Furthermore, eCATH1 was not cytotoxic against mammalian cells at bacteriolytic concentrations and maintained its high killing activity even at physiological salt concentrations. Our data suggest that equine AMPs, especially eCATH1, may be promising candidates for alternative drugs to control R. equi in mono- and coinfections.Keywords
This publication has 44 references indexed in Scilit:
- Human β-Defensin 2 and β-Defensin 3 Chimeric Peptides Reveal the Structural Basis of the Pathogen Specificity of Their Parent MoleculesAntimicrobial Agents and Chemotherapy, 2011
- Antimicrobial peptides and proteins of the horse - insights into a well-armed organismVeterinary Research, 2011
- Rhodococcus equi Infection in HIV-Infected Individuals: Case Reports and Review of the LiteratureAIDS Patient Care and STDs, 2010
- Resistance studies of erythromycin and rifampin for Rhodococcus equi over a 10-year periodIrish Veterinary Journal, 2007
- A novel horse α-defensin: gene transcription, recombinant expression and characterization of the structure and functionBiochemical Journal, 2007
- Human Antimicrobial Peptides: Defensins, Cathelicidins and HistatinsBiotechnology Letters, 2005
- In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equiJournal of Antimicrobial Chemotherapy, 2005
- Emergence of Rifampin-Resistant Rhodococcus equi with Several Types of Mutations in the rpoB Gene among AIDS Patients in Northern ThailandJournal of Clinical Microbiology, 2003
- Antimicrobial peptides of multicellular organismsNature, 2002
- Novel cathelicidins in horse leukocytesFEBS Letters, 1999